Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy Academic Article uri icon

Overview

MeSH Major

  • Antimetabolites, Antineoplastic
  • Fluorouracil
  • Gastrointestinal Neoplasms
  • Inflammatory Bowel Diseases

abstract

  • While there does appear to be an increased risk of diarrhea exacerbation in IBD patients treated with 5FU, a substantial number of patients tolerate chemotherapy without increased difficulty. The degree of IBD activity or other clinical parameters can not be used to predict accurately the likelihood of toxicity.

publication date

  • July 25, 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8683234

Additional Document Info

start page

  • 2043

end page

  • 6

volume

  • 14

number

  • 7